PARTI Overview We are a fully integrated commercial-stage innovative oncology company with an approved next-generation programmed death receptor-1 (PD-1) inhibitor, LOQTORZI (toripalimab-tpzi), and a pipeline that includes two mid-stage clinical candidates targeting liver, head and neck, colorectal and other cancers. Our strategy is to grow sales of LOQTORZI in nasopharyngeal carcinoma (NPC) and advance the development of new indications for LOQTORZI in combination with both our pipeline candida...
Q2 FY2026 — expected 2026-09-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001104659-26-025308 | EDGAR | 91K words |
| 2025-03-17 | 2024-12-31 | 0001558370-25-003126 | EDGAR | — |
| 2024-03-15 | 2023-12-31 | 0001558370-24-003436 | EDGAR | — |
| 2023-03-06 | 2022-12-31 | 0001558370-23-002917 | EDGAR | — |
| 2022-02-23 | 2021-12-31 | 0001558370-22-001764 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001558370-21-001829 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001564590-20-007416 | EDGAR | — |
| 2019-02-28 | 2018-12-31 | 0001564590-19-005470 | EDGAR | — |
| 2018-03-08 | 2017-12-31 | 0001564590-18-004947 | EDGAR | — |
| 2017-03-14 | 2016-12-31 | 0001564590-17-004176 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001104659-26-091262 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001104659-25-107852 | EDGAR | 60K words |
| 2025-08-07 | 2025-06-30 | 0001558370-25-010803 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001558370-25-007418 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001558370-24-014648 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011629 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007641 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0001558370-23-017779 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0001558370-23-012915 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0001558370-23-008529 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001558370-22-016850 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001558370-22-012251 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001104659-26-091188 | EDGAR | — |
| 2026-03-09 | 0001104659-26-025293 | EDGAR | 5K words |
| 2026-02-17 | 0001104659-26-016378 | EDGAR | — |
| 2026-02-04 | 0001104659-26-010065 | EDGAR | — |
| 2026-01-23 | 0001104659-26-006307 | EDGAR | — |
| 2026-01-13 | 0001104659-26-003117 | EDGAR | — |
| 2025-11-13 | 0001104659-25-111484 | EDGAR | — |
| 2025-11-06 | 0001104659-25-107780 | EDGAR | — |
| 2025-09-08 | 0001558370-25-011911 | EDGAR | — |
| 2025-08-07 | 0001558370-25-010802 | EDGAR | — |
282 total filings indexed. 250 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001512762 |
| Ticker | CHRS |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.coherus.com |
| Listed | 2014-11-06 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CHRS (~200 tokens, structured JSON with cryptographic provenance)